Testosterone recovery therapy targeting dysfunctional Leydig cells.
Sign Up to like & getrecommendations! Published in 2022 at "Andrology"
DOI: 10.1111/andr.13304
Abstract: INTRODUCTION Erectile dysfunction (ED) is associated with diabetes mellitus with an estimated prevalence of 52.5% in the diabetic population. The first-line therapy for ED are phosphodiesterase type 5 inhibitors (PDE5i), but data suggests that diabetic… read more here.
Keywords: testosterone recovery; diabetic men; therapy; recovery therapy ... See more keywords